These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6295268)

  • 1. Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults.
    Pollock AA; Tee PE; Patel IH; Spicehandler J; Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1982 Nov; 22(5):816-23. PubMed ID: 6295268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment.
    Patel IH; Sugihara JG; Weinfeld RE; Wong EG; Siemsen AW; Berman SJ
    Antimicrob Agents Chemother; 1984 Apr; 25(4):438-42. PubMed ID: 6329080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ceftriaxone in humans.
    Patel IH; Chen S; Parsonnet M; Hackman MR; Brooks MA; Konikoff J; Kaplan SA
    Antimicrob Agents Chemother; 1981 Nov; 20(5):634-41. PubMed ID: 6275779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age and ceftriaxone kinetics.
    Luderer JR; Patel IH; Durkin J; Schneck DW
    Clin Pharmacol Ther; 1984 Jan; 35(1):19-25. PubMed ID: 6317271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in blister fluid penetration after single and multiple doses of ceftriaxone.
    LeBel M; Grégoire S; Caron M; Bergeron MG
    Antimicrob Agents Chemother; 1985 Jul; 28(1):123-7. PubMed ID: 4037771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents.
    Patel IH; Weinfeld RE; Konikoff J; Parsonnet M
    Antimicrob Agents Chemother; 1982 Jun; 21(6):957-62. PubMed ID: 6287931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration.
    Borner K; Lode H; Hampel B; Pfeuffer M; Koeppe P
    Chemotherapy; 1985; 31(4):237-45. PubMed ID: 4028870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose pharmacokinetics of ceftriaxone in healthy Chinese adults.
    Zhou HH; Chan YP; Arnold K; Sun M
    Antimicrob Agents Chemother; 1985 Feb; 27(2):192-6. PubMed ID: 3985603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers.
    Meyers BR; Srulevitch ES; Jacobson J; Hirschman SZ
    Antimicrob Agents Chemother; 1983 Nov; 24(5):812-4. PubMed ID: 6318657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose.
    McNamara PJ; Stoeckel K; Ziegler WH
    Eur J Clin Pharmacol; 1982; 22(1):71-5. PubMed ID: 6284519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of ceftizoxime, a new cephalosporin. Single-dose study.
    Nakashima N; Suzuki K; Hashimoto H; Nishijima K
    J Clin Pharmacol; 1981 Oct; 21(10):388-95. PubMed ID: 6273456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose pharmacokinetics of ceftriaxone in infants and young children.
    Schaad UB; Stoeckel K
    Antimicrob Agents Chemother; 1982 Feb; 21(2):248-53. PubMed ID: 6280597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection.
    Scully BE; Fu KP; Neu HC
    Am J Med; 1984 Oct; 77(4C):112-6. PubMed ID: 6093511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose ceftriaxone kinetics in the newborn.
    Schaad UB; Hayton WL; Stoeckel K
    Clin Pharmacol Ther; 1985 May; 37(5):522-8. PubMed ID: 3987175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cefotiam administered intravenously and intramuscularly to healthy adults.
    Brisson AM; Bryskier A; Millerioux L; Fourtillan JB
    Antimicrob Agents Chemother; 1984 Oct; 26(4):513-8. PubMed ID: 6097166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects.
    Granneman GR; Sennello LT; Steinberg FJ; Sonders RC
    Antimicrob Agents Chemother; 1982 Jan; 21(1):141-5. PubMed ID: 6282203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ceftriaxone in pediatric patients with meningitis.
    Steele RW; Eyre LB; Bradsher RW; Weinfeld RE; Patel IH; Spicehandler J
    Antimicrob Agents Chemother; 1983 Feb; 23(2):191-4. PubMed ID: 6301362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime.
    Regamey C
    Chemotherapy; 1985; 31(2):85-94. PubMed ID: 3987394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.
    Del Rio M; McCracken GH; Nelson JD; Chrane D; Shelton S
    Antimicrob Agents Chemother; 1982 Oct; 22(4):622-7. PubMed ID: 6295262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose ceftriaxone kinetics in functionally anephric patients.
    Stoeckel K; McNamara PJ; Hoppe-Seyler G; Blumberg A; Keller E
    Clin Pharmacol Ther; 1983 May; 33(5):633-41. PubMed ID: 6301740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.